Monitoring agency report flags ₹1.30 crore AIF investment as deviation from issue objects
CARE Ratings, the monitoring agency for the ₹500.006 crore preferential issue, has issued its report for the quarter ended September 30, 2026.
By ScoutQuest · · 3 min read
- Deviation flagged
- ₹1.30 crore invested in Lumikai Fund II India Advantage Scheme (an AIF); deviation range up to 10%
- Issue size
- ₹500.006 crore preferential issue
- Proceeds received / pending
- ₹277.505 crore received in Q2FY27 from three investors; ₹78.000 crore still receivable from the fourth
What this update is
CARE Ratings Limited, the monitoring agency appointed for the preferential issue, has given its report for the quarter ended September 30, 2026. It reviews whether the money raised was used for the purposes stated in the offer document, and records the agency's observations along with the Board's comments.
The issue at a glance
- 1,82,31,000 convertible warrants, each convertible into one fully paid-up equity share of face value ₹ 2/-, at ₹ 260/- per warrant including a premium of ₹ 258/-.
- Issue size is stated as ₹ 500.006 crore on full conversion. After one proposed investor became ineligible, 1,82,31,000 warrants aggregating ₹474.006 crore were allotted to four eligible investors.
- 25% was paid upfront: ₹118.502 crore, equal to ₹65 per warrant. The balance 75% of ₹355.505 crore, equal to ₹195 per warrant, is payable on conversion within 18 months from June 04, 2026.
The deviation flagged
- During Q2FY27 the company invested ₹1.30 crore in Lumikai Fund II India Advantage Scheme, an AIF, and counted it as utilisation under the object "Expansion and Growth".
- The agency states that deployment of issue proceeds into an AIF as part of the object is not specifically mentioned in the offer document. The range of deviation is stated as up to 10%.
- The Board's comment: the object approved by members expressly includes "strategic investments in certain gaming sector investment vehicles"; Lumikai Fund II is a SEBI-registered AIF focused on gaming and interactive media; the investment is strategic, relates to the core sector and is 0.27% of the total issue size.
- The Board adds that 86.28% of the issue proceeds has been used towards "Expansion and Growth", including 0.28% in Lumikai Fund II, against a commitment of at least 75%, and 0.23% towards "General Corporate Purposes" against an approval of up to 25%.
Spending above the revised allocation
- The offer document allocated ₹375.01 crore to "Expansion and Growth", later revised to ₹355.50 crore after one investor became ineligible.
- Utilisation reported for Q2FY27 towards that object was ₹395.61 crore, exceeding the revised allocation by ₹40.11 crore, higher by 11.28%.
- A Board Resolution dated November 06, 2026 ratifies the excess by reallocating ₹40.11 crore from Object 2, "General Corporate Purposes and Preferential Issue Expenses", to Object 1, "Expansion and Growth".
Money received during the quarter
- ₹277.505 crore was received in Q2FY27 from three investors, being the entire 75% warrant subscription amount due from them.
- ₹277.50 crore of that was received in the Collection Account and transferred to the company's Current Account.
- As of September 30, 2026, ₹78.000 crore remained receivable from the fourth investor.
How to read this
The report records two differences of view rather than a single agreed position: the agency treats the AIF investment as outside the offer document's stated objects, while the Board says it falls within the approved object. Similarly, the excess spending is noted as a deviation and then ratified through a Board Resolution. Both sets of comments appear together in the same report, and the amounts involved are small relative to the issue size.
Also from Nazara Technologies
Nazara Technologies schedules one-on-one meeting with Jupiter Asset Management on November 19, 2026
16 Nov 2026
Nazara Technologies to hold six one-on-one investor meetings in Mumbai between November 18 and 23, 2026
13 Nov 2026
Nazara infuses USD 77.00 million into UK arm, pays second tranche for Bluetile and Bestplay
30 Oct 2026
More numbers
- Issue size on full conversion₹ 500.006 crore
- Convertible warrants allotted1,82,31,000
- Investment in Lumikai Fund II (AIF) in Q2FY27₹1.30 crore
- Utilisation towards Expansion and Growth in Q2FY27₹395.61 crore
- Revised allocation to Expansion and Growth₹355.50 crore
- Utilisation above revised allocation₹40.11 crore
- Received from three investors in Q2FY27₹277.505 crore
- Receivable from fourth investor as of September 30, 2026₹78.000 crore
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.